ArticleJournal of chemical information and modeling2026
Molecular Behavior of Human β Defensin Type 3 Embedded in Different Model Lipid Membranes.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human β defensin type 3 (hBD-3) is recognized as one of the most intriguing antimicrobial peptides (AMPs) that holds the promise of solving drug resistance issues. hBD-3 can function (disruption of membrane integrity) in high salt environments, where most other AMPs fail. However, its functional mechanism at the molecular level remains elusive. To characterize its structure and dynamics during membrane crossing, long-time (a total of 57.0 μs) all-atom molecular dynamics simulations were conducted on hBD-3 monomers and dimers in both wild-type and analog (in which all three disulfide bonds are broken) forms that are embedded in four types of lipid membranes. Trajectory analysis was carried out using a statistical method─conformational dynamics analysis to calculate contact matrices and then principal component analysis (PCA) and linear discriminant analysis (LDA), in order to discern structural changes upon various physical and chemical perturbations. The result shows that the major collective coordinate primarily distinguishes between the wild-type and analog forms of hBD-3. For the hBD-3 monomer, the analog undergoes significant structural loss due to the lack of stabilizing disulfide bonds; salt exerts a nearly consistent effect on the contact degrees of freedom of the protein, whereas changes in lipid membrane composition have an insignificant effect. For the hBD-3 dimer, no consistent relationship between structure and salt concentration is indicated, and variations in the chemical composition of model bacterial membranes have a limited effect on its dynamics. These results suggest that the wild-type and analog forms of hBD-3 may employ different mechanisms when crossing bacterial membranes. The effect of salt on hBD-3 dynamics can be mitigated by the high net charge density of the protein. Additionally, the hBD-3 dimer can distinguish between model Gram-positive and Gram-negative membranes, whereas the monomer cannot. Overall, these findings provide unique insights into the structure, dynamics, and membrane-disrupting mechanism of hBD-3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.